Drug candidate to enhance bone marrow transplant success
The drug makes the donor tissue less likely to destroy the patient’s organs, while allowing the regular immune activity against the cancer.
The drug makes the donor tissue less likely to destroy the patient’s organs, while allowing the regular immune activity against the cancer.